Sr IT Business Analysis Specialist at Gilead Sciences

La Verne, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s degree in IT, Computer Science, Engineering, or Pharmaceutical Manufacturing with at least 5 years of relevant experience with MES systems, preferably Körber PAS-X
OR Master’s degree in IT, Computer Science, Engineering, or Pharmaceutical Manufacturing with at least 3 years of relevant experience with MES systems, preferably Körber PAS-X
Strong understanding of pharmaceutical manufacturing processes and MES lifecycle

Responsibilities

Cultivate and apply working knowledge of Manufacturing, Facilities & Engineering, and Quality Control operations
Enhance GMP knowledge through Gilead’s Quality systems, validation strategy, SDLC approach, and testing methodology
Establish and maintain relationships with functional stakeholders to support business operations
Assess MES system requests for business need and technical feasibility; provide feedback and effort estimates
Collaborate with IT, production, and engineering teams to implement MES solutions that improve functionality
Manage and maintain the MES system (PAS-X), ensuring optimal performance and availability
Diagnose and resolve MES and SAP integration issues; act as the SAP point of contact for MES-related troubleshooting
Plan and execute system upgrades, patches, and enhancements
Conduct end-user training and maintain documentation of system configurations and procedures
Ensure MES compliance with industry standards and regulatory requirements
Provide on-site and on-call support during manufacturing activities
Perform root cause analysis for MES incidents and implement corrective actions
Participate in validation activities (IQ/OQ/PQ) and ensure compliance with GxP, GAMP, and 21 CFR Part 11
Maintain audit trails and documentation for inspections
Support MES workshops, design phases, and change management planning

Skills

MES

IT Support

Manufacturing Execution Systems

SAP

GMBR

ESPs

Digital Workflows

Troubleshooting

Server Management

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free